Expanding Our Novel Psychoactive Substances Test Offerings
SAN DIEGO, Calif. – August 15, 2022 – We are pleased to announce that, as of Monday, August 15, 2022, we are updating our definitive urine drug testing (UDT) menu to expand our novel psychoactive substances test offerings, based on surveillance data from the DEA and Center for Forensic Science Research and Education (CFSRE). Read More
Millennium Health and Ohio State University Researchers Work to Save Lives Amid the Substance Use Crisis with Study Published in JAMA Network Open
SAN DIEGO, Calif. – June 8, 2022 – A JAMA Network Open study, led by Millennium Health researchers, and co-authored by Rebecca Jackson, MD and Soledad Fernandez, PhD, of The Ohio State University College of Medicine, demonstrates a strong correlation between urine drug test (UDT) results and drug overdose deaths presenting a new opportunity in the fight against our nation’s substance use crisis.
Millennium Health and the University of Cincinnati Conducting NIDA-Funded Research Regarding Precipitated Withdrawal During Buprenorphine Induction
SAN DIEGO, Calif. – May 10, 2022 – Millennium Health, an accredited specialty laboratory specializing in medication monitoring and drug testing, is collaborating with investigators from the University of Cincinnati (UC) to investigate precipitated withdrawal during buprenorphine induction.
Oregon Experiencing Substantial Increase in Fentanyl Use for 2022
SAN DIEGO, Calif. – May 4, 2022 – A dramatic increase in drug overdose deaths, primarily due to illicit fentanyl, is being reported across the U.S.1 Contributing to these deaths is the proliferation of counterfeit pills often containing fentanyl that are nearly impossible to distinguish from authentic medications.2
Millennium Health VP, Scientific Affairs & Head of Clinical Data Programs Steven Passik, PhD Appointed to Board of Directors for International Health Facility Diversion Association
SAN DIEGO, Calif. – March 29, 2022 – The International Health Facility Diversion Association (IHFDA) has tapped the expertise of Millennium Health’s Vice President, Scientific Affairs & Head of Clinical Data Programs Steven Passik, PhD for its Board of Directors. Read More
Millennium Health Signals Report™ Volume 4 Highlights Substantial Changes in Illicit Drug Use Trends
Report Provides Recent Findings Regarding Known Contributors to Drug Overdose Deaths
SAN DIEGO, Calif. – February 9, 2022 – Drug overdose deaths in the U.S. are the highest ever recorded and are primarily driven by illicit fentanyl and methamphetamine.1Read More
SAN DIEGO, Calif. – January 19, 2022 – Celebrating the New Year with a look back at some of our important work from 2021. Many exciting things to come in 2022!Read More
Millennium Health Appoints Scott Walton as Chief Executive Officer
SAN DIEGO, Calif. – October 26, 2021 – Millennium Health, a national leader in specialty medication monitoring and drug testing, today announced the appointment of Scott Walton as Chief Executive Officer (CEO) effective immediately.Read More
Millennium Health Study Published in Drug and Alcohol Dependence Highlights COVID-19, Seasonal and Regional Influences on Alcohol Consumption
SAN DIEGO, Calif. – October 5, 2021 – According to the Centers for Disease Control and Prevention (CDC), excessive alcohol use remains the leading cause of preventable death in the U.S., with over 95,000 deaths every year due to alcohol-related causes.1 Read More
Distinguished Psychologist and Addiction Specialist Joins Millennium Health Management Team
SAN DIEGO, Calif. – September 22, 2021 – Specialty medication monitoring and drug testing company, Millennium Health today announced leading pain and addiction expert, Steven D. Passik, PhD has joined its management team as VP, Scientific Affairs and Head of Clinical Data Programs. Dr. Passik will focus primarily on expanding work begun at Millennium Health to inform clinicians, policy makers and public health officials about the changing landscape of substance abuse to help facilitate a data driven approach to this enormous public health problem.
Patient Billing
(877) 451-7337
Monday-Friday 6:00AM-4:00PM PT
Corporate Headquarters
(877) 451-3534
